Musculoskeletal diseases Musculoskeletal Diseases Musculoskeletal diseases not otherwise specified
Conditions
Interventions
Control:
Usual care involves patients being referred by a GP to a physiotherapist. Patients then wait for an initial face-to-face physiotherapy assessment and then usually have follow-up appointments
Sponsors
University of Bristol (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 07/05/2009: 1. Adults (aged 18 years and over), either sex 2. Adults requiring musculoskeletal physiotherapy who are referred by General Practitioners (GPs), other members of the primary health care team, or who are self-referred Previous inclusion criteria: 1. Adults (aged 18 years and over), either sex 2. Referred by General Practitioners (GPs) for physiotherapy
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 07/05/2009: 1. Children (less than 18 years) 2. Patients referred to physiotherapy by a hospital consultant, emergency department or primary/secondary care interface service 3. Those needing domiciliary physiotherapy 4. Those needing post-operative physiotherapy 5. Those unable to communicate by telephone in English 6. Those needing physiotherapy for non-musculoskeletal problems Previous exclusion criteria: 1. Children (less than 18 years) 2. Patients referred to physiotherapy by a hospital consultant 3. Those needing domiciliary physiotherapy 4. Those needing post-operative physiotherapy 5. Those unable to communicate by telephone in English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 07/05/2009: 1. Clinical outcome at 6 months, measured using the physical component summary (PCS) measure from the 36-item short form health survey version 2 (SF-36v2) 2. Incremental cost-effectiveness will be measured in terms of Quality Adjusted Life Years (QALYs), assessed using the EQ5D measure and costs Outcomes will be assessed at baseline, and 6 weeks and 6 months after randomisation. Previous primary outcome measures amended in record as of 17/02/2009 (protocol amendment on the 21/11/2008): 1. Clinical outcome at 6 months, measured using the physical component summary (PCS) measure from the 36-item short form health survey version 2 (SF-36v2) 2. Incremental cost-effectiveness will be measured in terms of Quality Adjusted Life Years (QALYs), assessed using the SF-6D measure and costs Outcomes will be assessed at baseline, and 6 weeks and 6 months after randomisation. Initial information at the time of registration: 1. Clinical improvement at 6 months, measured using the physical component summary (PCS) measure from the 36-item short form health survey version 2 (SF-36v2) and the Measure Yourself Medical Outcome Profile (MYMOP questionnaire) 2. Incremental cost-effectiveness will be measured in terms of Quality Adjusted Life Years (QALYs), assessed using the SF-6D measure and costs Outcomes will be assessed at baseline, and 6 weeks and 6 months after randomisation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 07/05/2009: 1. Costs 2. Quality of life (EQ5D) 3. The individual scales and the mental component summary measure from SF-36 4. Individual overall perception of improvement (seven point Likert scale from 'very much worse' to 'very much better') 5. Waiting times for treatment 6. Time lost from work and usual activities 7. Patient satisfaction with the care provided 8. Preference for telephone or face-to-face assessment 9. Clinical outcome using the Measure Yourself Medical Outcome Profile (MYMOP questionnaire) Outcomes will be assessed at baseline, and 6 weeks and 6 months after randomisation. Amended in record as of 17/02/2009 (protocol amendment on the 21/11/2008): The following secondary outcome was added to this list: 10. Clinical outcome using the Measure Yourself Medical Outcome Profile (MYMOP questionnaire) Initial information at the time of registration: 1. Costs 2. Quality of life (EQ5D) 3. The individual scales and the mental component summary measure from SF-36 4. Individual overall perception of improvement (seven point Likert scale from 'very much worse' to 'very much better') 5. Waiting times for treatment 6. Time lost from work and usual activities 7. Patients' perceptions of the accessibility of care 8. Satisfaction with care provided (based on CSQ8) 9. Preference for telephone or face-to-face assessment Outcomes will be assessed at baseline, and 6 weeks and 6 months after randomisation. | — |
Countries
United Kingdom
Outcome results
None listed